NEUPNasdaqPharmaceutical PreparationsFiscal year ends June 30
Neuphoria Therapeutics Inc.
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-K on Sep 18, 2026
$3.31+0.01 (+0.30%)
Close on Oct 19, 2026
- Market cap
- $17.90M
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
40 of Neuphoria Therapeutics's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Annual report | 10-K | Jun 30, 2026 | Sep 18, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Nov 2, 2026 | Sep 18, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 20, 2026 | Jul 24, 2026 | SEC EDGAR |
| Current report | 8-K | May 21, 2026 | May 26, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 15, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Dec 31, 2025 | Feb 17, 2026 | SEC EDGAR |
| Current report | 8-K | Dec 31, 2025 | Jan 8, 2026 | SEC EDGAR |
| Current report | 8-K | Dec 18, 2025 | Dec 18, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 12, 2025 | Dec 17, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 14, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Dec 9, 2025 | Oct 30, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 27, 2025 | Oct 27, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 20, 2025 | Oct 20, 2025 | SEC EDGAR |
| Annual report | 10-K | Jun 30, 2025 | Sep 29, 2025 | SEC EDGAR |
| Current report | 8-K | Sep 10, 2025 | Sep 16, 2025 | SEC EDGAR |
| Current report | 8-K | Jul 18, 2025 | Jul 18, 2025 | SEC EDGAR |
| Current report | 8-K | May 20, 2025 | May 20, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 20, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Dec 31, 2024 | Feb 14, 2025 | SEC EDGAR |
| Current report | 8-K | Jan 10, 2025 | Jan 14, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 23, 2024 | Dec 23, 2024 | SEC EDGAR |
| Current report | 8-K | Dec 16, 2024 | Dec 16, 2024 | SEC EDGAR |
| Current report | 8-K | Dec 11, 2024 | Dec 12, 2024 | SEC EDGAR |
| Current report | 8-K | Nov 18, 2024 | Nov 21, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2024 | Nov 14, 2024 | SEC EDGAR |
| Proxy statement | DEF 14A | Dec 11, 2024 | Nov 12, 2024 | SEC EDGAR |
| Current report | 8-K | Nov 8, 2024 | Nov 8, 2024 | SEC EDGAR |
| Current report | 8-K | Oct 9, 2024 | Oct 10, 2024 | SEC EDGAR |
| Current report | 8-K | Oct 1, 2024 | Oct 2, 2024 | SEC EDGAR |
| Annual report | 10-K | Jun 30, 2024 | Sep 30, 2024 | SEC EDGAR |
| Current report | 8-K | Jul 11, 2024 | Jul 16, 2024 | SEC EDGAR |
| Current report | 6-K | Jun 3, 2024 | Jun 3, 2024 | SEC EDGAR |
| Current report | 6-K | Mar 15, 2024 | Mar 15, 2024 | SEC EDGAR |
| Annual report, amended | 20-F/A | Jun 30, 2023 | Jan 17, 2024 | SEC EDGAR |
| Current report | 6-K | Jan 4, 2024 | Jan 4, 2024 | SEC EDGAR |
| Current report | 6-K | Nov 30, 2023 | Nov 30, 2023 | SEC EDGAR |
| Current report | 6-K | Nov 28, 2023 | Nov 28, 2023 | SEC EDGAR |
| Current report | 6-K | Nov 3, 2023 | Nov 3, 2023 | SEC EDGAR |
| Annual report | 20-F | Jun 30, 2023 | Oct 18, 2023 | SEC EDGAR |
| Current report | 6-K | Oct 16, 2023 | Oct 16, 2023 | SEC EDGAR |